University Of Rome Tor Vergata
Clinical trials sponsored by University Of Rome Tor Vergata, explained in plain language.
-
Scientists track blood clues to improve hepatitis d treatment
Knowledge-focused Not yet recruitingThis study aims to learn more about how patients with chronic hepatitis D (HDV) respond to a treatment called bulevirtide (BLV). Researchers will analyze existing and future blood samples from about 220 patients to see how their virus levels change over time. The main goal is to …
Sponsor: University of Rome Tor Vergata • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:34 UTC
-
Seeking a better warning sign for dangerous virus after transplants
Knowledge-focused Not yet recruitingThis study aims to find better ways to monitor for a dangerous virus called CMV in adults who have received a stem cell transplant. Researchers will track 290 patients to see if measuring different virus markers in the blood (CMV-RNA and TTV-DNA) can more accurately predict when …
Sponsor: University of Rome Tor Vergata • Aim: Knowledge-focused
Last updated Mar 16, 2026 15:24 UTC